dr huberman bpc 157 Peptides: The Science, Uses & Safety | Dr. Abud Bakri - Lab Andrew Huberman on Reels |

Synthetic Lipolytic Domain Characterization Ng et al., Hormone Research (2000) Ng and colleagues conducted foundational characterization studies of the AOD-9604 synthetic lipolytic domain using a combination of in vitro adipocyte assays and in vivo obese Zucker rat models

If side effects persist or worsen, consult a healthcare provider

Clinical trials consistently demonstrate 10-12% body weight loss with monotherapy, and 15-25% when combined with semaglutide

But there exists a hazy gray area in between which can complicate matters

However, it's important to remember that BPC-157 is still being studied, and we don't yet know everything about it